Nucleon

1. Describe the vertical chain for biotechnology productions. What "make" decisions has Nucleon already made? What "buy" decisions has it already made? Evaluate these decisions.

2. Draw a decision tree for stage I/II/III

3. How would you go about evaluating which option to take using the decision tree? (you dont need to do this just discuss the approach)

4. What make or buy decisions confront Nucleon in this case? Are there any other options besides those mentioned in the case that Nucleon might explore?

5. What other factors must Nucleon consider before reaching a final decision? When all factors are taken together, what should Nucleon do? During this piece of the evaluation, see if you can identify where the following concepts appear

Specific assets

Leakages

Possible coordination costs

Which must come first? Long term strategy consideration or production strategy for CRP-I?